Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-10-036954
Filing Date
2010-07-07
Accepted
2010-07-07 17:01:55
Documents
8
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 v190023_10k.htm 10-K 2720651
2 v190023_ex21.htm EX-21 2371
3 v190023_ex23-1.htm EX-23.1 4385
4 v190023_ex23-2.htm EX-23.2 4288
5 v190023_ex31-1.htm EX-31.1 15629
6 v190023_ex31-2.htm EX-31.2 15635
7 v190023_ex32-1.htm EX-32.1 7305
8 v190023_ex32-2.htm EX-32.2 7281
  Complete submission text file 0001144204-10-036954.txt   2778932
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /DE/ (Filer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-15697 | Film No.: 10942405
SIC: 2834 Pharmaceutical Preparations